Showing results (11-20 of 312) with videos related to
Sort By:
Pageof 32
Medical and Pediatric Oncology|November 1, 1996
Functional properties of WT1D A Haber, C Englert, S MaheswaranBritish Journal of Cancer|September 18, 2008
In vitro phosphorylation of BRCA2 by the checkpoint kinase CHEK2S Kim, G Mohapatra, D A HaberBehavioral Medicine (Washington, D.C.)|February 19, 1999
Disability in older adults. 3: Policy implicationsD A Chiriboga, K Ottenbacher, D A HaberCancer Research|October 15, 1993
Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumorS Park, G Tomlinson, P Nisen, et al.Cell|November 11, 1999
DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian developmentM Okano, D W Bell, D A Haber, et al.Genes & Development|September 1, 1995
The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosisS Maheswaran, C Englert, P Bennett, et al.Cell|September 18, 1999
The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulinS B Lee, K Huang, R Palmer, et al.Genes & Development|May 30, 1998
Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70S Maheswaran, C Englert, G Zheng, et al.The Journal of Biological Chemistry|September 25, 1981
Properties of an altered dihydrofolate reductase encoded by amplified genes in cultured mouse fibroblastsD A Haber, S M Beverley, M L Kiely, et al.Cancer Research|April 15, 1997
Induction of p21 by the Wilms' tumor suppressor gene WT1C Englert, S Maheswaran, A J Garvin, et al.Pageof 32